Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-12-19
DOI
https://doi.org/10.3389/fimmu.2025.1761945
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

Qiang Zou, Xueli Cui, Jingji Jin, Yingying Li et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

Qiang Zou, Xueli Cui, Jingji Jin, Yingying Li, Feng Xue, Yong Cai, Yunxiao He, Aiping Wen
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
North Sichuan Medical University (CN), Jilin University (CN), Changchun Discovery Sciences (China) (CN), Affiliated Hospital of North Sichuan Medical College (CN), Jilin International Studies University (CN)
Openalex Percentile: Top 43%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.